Filing Details

Accession Number:
0000950170-24-099887
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-22 16:43:06
Reporting Period:
2024-08-20
Accepted Time:
2024-08-22 16:43:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1217234 Caredx Inc. CDNA Services-Medical Laboratories (8071) 943316839
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1613855 Peter Maag C/O Caredx, Inc.
8000 Marina Boulevard
Brisbane CA 94005
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-08-20 26,708 $7.96 365,576 No 4 M Direct
Common Stock Disposition 2024-08-20 8,844 $33.23 356,732 No 4 S Direct
Common Stock Disposition 2024-08-20 13,890 $33.25 342,842 No 4 S Direct
Common Stock Disposition 2024-08-20 12,818 $32.67 330,024 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2024-08-20 26,708 $0.00 26,708 $7.96
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,428 2033-06-16 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.75, inclusive. The reporting person undertakes to provide to CareDx, Inc.,any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes(1) and (2) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.345 to $33.000, inclusive.
  3. This option was originally granted on June 16, 2023 and, as of June 16, 2024, was fully vested.